The Director of the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Dr. Ramon Gomis, has been awarded with the Creu de Sant Jordi 2013, together with 24 other personalities and 25 institutions. The Creu de Sant Jordi 2013 is the recognition that the Government of Catalonia awards to individuals and institutions for their outstanding services to Catalonia in politics, society or culture. Dr. Gomis is an endocrinologist with a long career at the Hospital Clínic of Barcelona, professor at the University of Barcelona and influent scientist in diabetes, combined with a solid career as a writer.
Archive for the ‘Hospital Clínic’ Category
Bipolar disorder is a serious psychiatric condition very common, affecting about 2 or 3% of the general population. This disease also affects in sick leaves hospitalization and social problems. Many patients also present suicidal behavior. Patients who do not take drug treatments have high autolytic risk. It is estimated that the risk of death by suicide, particularly in unmedicated patients reaches 15%. Suicide is a very complex behavior which is believed that, like other psychiatric diseases, there are many small effect genes interact with each other and also interact with other types of environmental factors, psychological or psychosocial.
Researchers Bipolar Disorders Program of the IDIBAPS – Hospital Clínic, leded by Dr. Eduard Vieta, have published a study in the journal European Neuropsychopharmacology, which shows that there are genetic aspects determining suicidality of bipolar patients. Results approach suicide concept to a biological basis, bringing it closer to the disease. Dr. Antoni Benabarre is the principal investigator and the IDIBAPS predoctoral fellow, Esther Jimenez, the first signer. Read the rest of this entry »
For the first time a multicentre study, including data from all around Spain, shows that telemedicine reduced in a 50% the economic impact of visits to the hospital in patients with type 1 diabetes mellitus. It spares time to the patient, and also to the healthcare professional. This is demonstrated by the preliminary results of the Telemed-Diabetes Study, conducted by the Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) funded by the Institute of Health Carlos III (Ministry of Economy and Competitiveness), which were presented last Saturday at the XXIV Congress of the Spanish Society of Diabetes, held in Seville. Dr. Enric Esmatjes, IDIBAPS researcher at the Diabetes: metabolic and molecular networks team and Head of Diabetes Unit at Hospital Clínic of Barcelona, coordinates this study evaluating the cost-effectiveness of telematic systems applied to the treatment of type 1 diabetes mellitus.
Information via: CIBERDEM
IDIBAPS participates in 10 of the 50 most influential works of the last 10 years with Spanish participation
The Centre for Research Survey of the Institute of Catalan Studies (Observatori de la Recerca de l’Institut d’Estudis Catalans) publishes almost half of the most cited researchers in Spain work in Catalonia. IDIBAPS is, with 10 articles, the Catalan center which appears in a greater number of jobs among the 50 most cited papers with Spanish participation. These data confirm once again the significance of Catalan research and IDIBAPS, Hospital Clinic of Barcelona Faculty of Medicine and University of Barcelona leadership.
Reuse of pacemakers is a good solution to make these devices more accessible in developing economies
In developing economies, there are patients in whom pacemaker implantation is delayed because they cannot afford one. Reused devices have been a solution. To address concerns about safety, a cohort of consecutive patients implanted with a reused pacemaker was compared with a control group. This research was conducted in the Department of Electrocardiology at the Instituto Nacional de Cardiología Ignacio Chávez (México), and counted with the collaboration of the Department of Cardiology at Hospital Clínic – IDIBAPS of Barcelona. The last authors of the article published in Circulation are Dr. Josep Brugada, Medical Director at the Hospital Clínic and team leader at IDIBAPS, and Dr. Pedro Iturralde, head of the Electrocardiology Department at the Mexican center.
Idiopathic rapid-eye-movement sleep behaviour disorder is the prodromal phase of neurodegenerative diseases
A series of works, led from the Neurology Service at the Hospital Clínic – IDIBAPS of Barcelona, show that idiopathic rapid-eye-movement (REM) sleep behaviour disorder (IRBD) represents the prodromal phase of neurodegenerative diseases, such as dementia with Lewy bodies (DLB) or Parkinson’s disease (PD). Patients suffering REM sleep behaviour disorders dream nightmares in which they are attacked and pursued, with the particularity that they express them by screaming, crying, punching and kicking while sleeping. Lancet Neurology has published four consecutive works about the relationship between this disorder and Parkinson’s disease. The first author of these articles is Dr. Àlex Iranzo, doctor from the Neurology Service at the Hospital Clínic of Barcelona and researcher at the IDIBAPS and member of the Multidisciplinary Sleep Disorders Unit, and the senior authors were to Dr. Joan Santamaria and Dr. Eduard Tolosa, from the same institution.